The First Affiliated Hospital with Nanjing Medical University clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
10 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 9 with minor changes only.
- Notable: Goal-directed LCVP Based on HP in Laparoscopic Hepatectomy Enrollment increased: 100 → 160 participants
-
Minor: 6 trials marked Unknown by the registry's verification sweep Changed
- Minor: Ribociclib Combined With AI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel) Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Lactobacillus Vaginalis Capsules · Vulvovaginal Atrophy in Young Breast Cancer Patients Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Thiotepa and Pomalidomide · Relapsed/Refractory Primary Central Nervous System Lymphoma Patients Changed Registry marked status Unknown (sponsor has not verified the record since Jun 2023); last known: Recruiting
- Minor: Multi-parametric Functional MRI in Patients of Chronic Kidney Disease Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: High Resolution Diffusion Weighted Imaging in Prostate Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Development of Tinnitus · SSNHL: Insights From fMRI and Metabolomics Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Minor: Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy Sponsor refiled this as recruiting (was completed)
- Minor: H-FROG · Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial Interventions modified
- Minor: Durvalumab as Consolidation Therapy · LS-SCLC Following sCRT Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-03 | NCT07912606 D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy… | Phase 2 | Not Yet Recruiting |
| 2026-10-30 | NCT07906652 Clinical Evaluation of the Safety and Efficacy of "Buyan Huan Wu Tang" Combined With… | Early Phase 1 | Enrolling by Invitation |
| 2026-10-29 | NCT07902596 Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma | Not Yet Recruiting | |
| 2026-10-28 | NCT07900516 A Prospective, Phase II, Exploratory Study Protocol of a Chemotherapy Sensitivity-based… | Phase 2 | Recruiting |
| 2026-10-26 | NCT07894640 Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula… | Early Phase 1 | Enrolling by Invitation |
| 2026-10-22 | NCT07888621 Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and… | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 13 | |
| Phase 1 | 8 | |
| Phase 1/2 | 5 | |
| Phase 2 | 85 | |
| Phase 3 | 13 | |
| Phase 4 | 9 |
Not charted: 120 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 46
Breast Cancer (33) · Gastric Cancer (26) · Non-Hodgkin Lymphoma (22) · Heart Disease (15) · Colorectal Cancer (12) · DLBCL (11) · Esophageal Cancer (9) · Leukemia (8) · Heart Failure (7) · Cholangiocarcinoma (6)
Get alerts when The First Affiliated Hospital with Nanjing Medical University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.